Nomura Holdings’s Neurogene NGNE Stock Holding History

Nomura Holdings’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$257K	Buy	+12,724	New	+$246K	﹤0.01%	1520
2023 Q1	–	Sell	-812	Closed	-$8K	–	1647
2022 Q4	$8K	Hold	812	–	–	﹤0.01%	1383
2022 Q3	$11K	Hold	812	–	–	﹤0.01%	1525
2022 Q2	$16K	Buy	812 +37	+5%	+$903	﹤0.01%	1626
2022 Q1	$29K	Buy	775 +13	+2%	+$758	﹤0.01%	1805
2021 Q4	$74K	Sell	762 -13	-2%	-$1.58K	﹤0.01%	2027
2021 Q3	$114K	Hold	775	–	–	﹤0.01%	1763
2021 Q2	$145K	Hold	775	–	–	﹤0.01%	1790
2021 Q1	$190K	Hold	775	–	–	﹤0.01%	1650
2020 Q4	$221K	Buy	+775	New	+$189K	﹤0.01%	1377

Other funds holding NGNE

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TECP

Trails Edge Capital Partners Atlanta, Georgia $437M AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Nomura Holdings's NGNE Position: Q1 2026 in Review

Nomura Holdings opened a new position in Neurogene (NGNE) in Q1 2026: 12,724 shares worth $257K. The stake represents ﹤0.01% of the portfolio and ranks #1520 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in NGNE as recently as Q4 2022.

Nomura Holdings first reported a position in NGNE in Q4 2020 and has held it in 10 quarters since. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

Nomura Holdings held 12,724 shares of Neurogene worth $257K as of Q1 2026.
Neurogene was a new Nomura Holdings position in Q1 2026.
Neurogene made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1520 holding.
Nomura Holdings first reported a position in Neurogene in Q4 2020 and has held it in 10 quarters since.
96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.